TSE:CGY

56.84
0.34 (0.60%) 1d
0

Related posts

Most Anticipated Earnings: UNC-T, DAN-X and more Canadian Companies Reporting Earnings this Week (Nov 27-Dec 01)
Investor Insights

This summary was created by AI, based on 3 opinions in the last 12 months.

Despite a strong record quarter in terms of revenues and growth, CGY-T stock had a mixed performance in the 2Q numbers release. The company is expected to display decent growth next year with significant EPS and revenue increase, however, with lower than expected sales. The stock is perceived as having a stable business with ample balance sheet flexibility for potential M&A activities and future expansion. Despite the mixed results, the experts view it as a HOLD with potential for future growth and margin expansion.

Consensus
HOLD
Valuation
Fair Value
Similar
TLS, Telos Corporation
HOLD
Calian Group Ltd
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

In Q4, CGY recorded both EPS and revenue beating analysts’ forecasts. EPS came in at $1.07 versus analysts’ estimates of $0.956. Revenue beat estimates of $170.54M, coming in at $175.95 and displaying a 9.6% year-over-year growth. This was a record quarter for CGY in terms of revenues, adjusted EBITDA, and gross margin. Management stated that CGY will come in at the midpoint of guidance for FY2023 which would display a year-over-year revenue growth of 15% and adjusted EBITDA growth of 32%. EPS growth is expected to be significant next year, above 32% while revenues are also expected to see solid growth at 14.5%. Despite being down year-to-date, we think that CGY has a very stable business and following the strong quarterly results it is already ticking back up. We view it as a HOLD.
Unlock Premium - Try 5i Free

consulting
HOLD
Calian Group Ltd
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

CGY released 2Q numbers; EPS of 40c was nowhere near estimates of $1.04; Revenue of $166.5M matched estimates. Revenue rose 11%. Free cash flow was $11M. New contracts were $131M. Higher costs and investments hurt results, and the company has identified $8M in cost savings but it will take a charge to earnings. It also updated its guidance and sales are now expected to be lower than previously expected. CGY has a strong balance sheet and growth is expected next year. Not a great quarter but with the stock hit already and the low valuation we would see it as a HOLD right now. 
Unlock Premium - Try 5i Free

consulting
BUY
Calian Group Ltd
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

There is ample balance sheet flexibility to allow for more acquisitions. Further expansion in the US or other areas of service can definitely lead to potential M&A activities as it has before. There is decent growth expected over the next few years with margin expansion and integrations to be the primary goal. It is more attractive now at 14x forward earnings (lower end of the five-year range) and with CGY being debt-free and with solid growth, things look good. We don't do price targets, however, we do think that is achievable. 
Unlock Premium - Try 5i Free

consulting
BUY
Calian Group Ltd

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The balance sheet is pristine and has excess cash. Growth is expected to be moderate with improving margins. Relatively cheap compared to historic levels. Valuation is okay at 17x earnings. You would but for income not growth. Unlock Premium - Try 5i Free

consulting
HOLD
Calian Group Ltd
He used to own this when it traded $5. Earnings have been very good over the past couple of years. A shelf prospectus is rumoured to be in the works for a potential acquisition. He likes the management team. Continue to hold it.
consulting
WEAK BUY
Calian Group Ltd
They have a lot of government contracts, which is good, but low-margin. CGY doesn't need a lot of capital, which is a plus. It's a slow, steady, cheap company. It's alright, boring. If there's a recession, this will be consistent.
consulting
BUY ON WEAKNESS
Calian Group Ltd
He used to own it. There is a new CEO now. They are diversifying their business base. It is turning into a growth company. The stock has gotten a little expensive. Buy it on a dip, or hang on to it.
consulting
PAST TOP PICK
Calian Group Ltd

(Past Top Pick Sept. 29, 2017, Up 9%) Health IT training services and managing health delivery for Canadian Armed Forces families (out of Saskatoon); also do pharmacies in Loblaws. Companies are happy to outsource these services to CGY. Offers one of the higher returns in invested capital among medium-sized stocks.

consulting
BUY
Calian Group Ltd

Difficult company to describe. They are in different segments. They have a Health Care Clinical Management segment, they do emergency response training and they are also in manufacturing for satellite and some other work. They brought a new CEO a few years back and he has put some good initiatives to drive growth.

consulting
BUY
Calian Group Ltd

See Past Picks today. This one is fairly diversified. It was a top pick previously and he still owns it and is still enthusiastic about it.

consulting
PAST TOP PICK
Calian Group Ltd

(A Past Top Pick Jul 14/16, Up 69%) A variety of aerospace businesses. There has been a big secular move as more and more countries have begun to travel. There is a lot of technology consulting coming down the pipe. We will need these tech consulting firms.

consulting
TOP PICK
Calian Group Ltd

It does 145 pharmacies by Loblaw’s (L-T) and medical services for the Canadian Defence Department, as well as a satellite business out of Saskatoon. One of the most consistently profitable small-cap companies for the last 5 years. 4% dividend yield. (Analysts’ price target is $31.00.)

consulting
DON'T BUY
Calian Group Ltd

He used to own it a long time ago. It stalled out and he sold. It is finally getting traction again. They are trying to diversify the business. If they lose a big contract it could really impact the results. The dividend is safe. He would like to buy it much more cheaply but he would not buy at these levels.

consulting
WEAK BUY
Calian Group Ltd

It has a great balance sheet. They supply IT professionals to governments. It went on a tear after doing nothing for 5 years. The valuation is low and business is very stable. Treat it as an income stock. They keep buying back stock. It is not a bad little company.

consulting
HOLD
Calian Group Ltd

(Market Call Minute.) They have done well operationally.

consulting
Showing 1 to 15 of 60 entries

Calian Group Ltd(CGY-T) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 2

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 3

Stockchase rating for Calian Group Ltd is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Calian Group Ltd(CGY-T) Frequently Asked Questions

What is Calian Group Ltd stock symbol?

Calian Group Ltd is a Canadian stock, trading under the symbol CGY-T on the Toronto Stock Exchange (CGY-CT). It is usually referred to as TSX:CGY or CGY-T

Is Calian Group Ltd a buy or a sell?

In the last year, 3 stock analysts published opinions about CGY-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Calian Group Ltd.

Is Calian Group Ltd a good investment or a top pick?

Calian Group Ltd was recommended as a Top Pick by on . Read the latest stock experts ratings for Calian Group Ltd.

Why is Calian Group Ltd stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Calian Group Ltd worth watching?

3 stock analysts on Stockchase covered Calian Group Ltd In the last year. It is a trending stock that is worth watching.

What is Calian Group Ltd stock price?

On 2024-03-27, Calian Group Ltd (CGY-T) stock closed at a price of $56.84.